Cargando…
A truncated HIV Tat demonstrates potent and specific latency reversal activity
A major barrier to HIV-1 cure is caused by the pool of latently infected CD4 T-cells that persist under combination antiretroviral therapy (cART). This latent reservoir is capable of producing replication-competent infectious viruses once prolonged suppressive cART is withdrawn. Inducing the reactiv...
Autores principales: | Van Gulck, Ellen, Pardons, Marion, Nijs, Erik, Verheyen, Nick, Dockx, Koen, Van Den Eynde, Christel, Battivelli, Emilie, Vega, Jerel, Florence, Eric, Autran, Brigitte, Archin, Nancie M., Margolis, David M., Katlama, Christine, Hamimi, Chiraz, Van Den Wyngaert, Ilse, Eyassu, Filmon, Vandekerckhove, Linos, Boden, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649039/ https://www.ncbi.nlm.nih.gov/pubmed/37874295 http://dx.doi.org/10.1128/aac.00417-23 |
Ejemplares similares
-
Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells
por: Dinesh Kumar, Nilima, et al.
Publicado: (2022) -
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study
por: Dumont, Etienne F., et al.
Publicado: (2020) -
Phase 2 Open-Label Study of Long-Term Safety, Tolerability, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive Adolescents Living with HIV-1
por: Lombaard, Johan, et al.
Publicado: (2022) -
Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018) -
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
por: Ulferts, Rachel, et al.
Publicado: (2016)